metabolic health | Jan Medical Group

All Posts
Health and Lifestyle
Weight Loss
Nutrition
Exercise
Mental Health
Weight Loss Medication
Body Sculpting

Understanding Mounjaro: Why It’s Part of Today’s Weight-Health Conversation

If the name Mounjaro keeps showing up in conversations, sometimes casually, sometimes with curiosity, it reflects a broader change in how people are thinking about weight, appetite, and metabolic health. The tone of the discussion has shifted. It’s no longer just about discipline or rigid rules, but about why certain patterns are hard to change even when effort is already there. More people are asking better questions. A different kind of curiosity What’s interesting is that

Joshua Mitre

Jan 163 min read

A New Chapter in Weight Management: The Arrival of the First FDA-Approved Weight-Loss Pill

The conversation around weight management is changing, and this time, it’s not driven by hype, social media trends, or extreme promises. In December 2025, Novo Nordisk received U.S. FDA approval for the first oral GLP-1–based weight-loss pill , a tablet version of its well-known injectable therapy, Wegovy. This marks a pivotal moment not only for pharmaceutical innovation, but for how people may finally access sustainable, medically supported weight loss. For years, injecta

Joshua Mitre

Dec 23, 20253 min read

Understanding Body Changes: A Closer Look at Mesolipo and Modern SHAPE-Style Programs

In recent years, many people have become more curious about how the body stores fat, why certain areas feel “stubborn,” and what science-based options exist beyond the usual diet-and-workout cycle. This curiosity has opened the door to conversations about approaches like Mesolipo and structured metabolic programs similar to SHAPE-style frameworks used in medical clinics. This article aims to explain these concepts in a calm, educational way, no persuasion, no promises, just

Joshua Mitre

Nov 14, 20252 min read

Beyond the Scale: Tracking Non-Weight Loss Benefits of GLP-1 Therapy (Blood Pressure, Inflammation, Sleep)

When you begin Semaglutide ( Ozempic/Wegovy ) or Tirzepatide ( Mounjaro/Zepbound ), the first thing you notice is the weight loss . It’s the headline result, and often the primary reason people seek treatment. But what if we told you the most profound transformation is the one happening beneath the surface? At Jan Medical Group , we view GLP-1 therapy not just as a weight loss tool, but as a holistic agent for metabolic renewal. The long-term, non-weight-related benefits—i